Biopharmaceutical Fermentation Systems Market to Reach $38.39 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Biopharmaceutical Fermentation Systems Market In 2029?
In recent times, the market size of biopharmaceutical fermentation systems has seen a significant increase. The market, which is anticipated to rise from $24.61 billion in 2024 to $26.86 billion in 2025, will grow at a compound annual growth rate (CAGR) of 9.1%. The increase during the historic period can be linked to a rise in demand for biologics, supportive regulations, industry consolidation, an upward trend in research and development investment, and a changing healthcare landscape.
What Growth Rate Is Forecasted for the Biopharmaceutical Fermentation Systems Market by 2029?
The biopharmaceutical fermentation systems market is projected to witness robust growth over the coming years, anticipated to reach $38.39 billion by 2029 with a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the growth during this forecast period include expansion of the biopharmaceutical pipeline, the shift towards personalised medicine, adoption of continuous bioprocessing, growth in emerging markets, and advancements in automation and digitalisation. Key trends to look out for during this period include a spike in the adoption of continuous manufacturing, growth in the personalised medicine sector, the expansion of the biosimilars market, the integration of advanced analytics and AI, and a focus on sustainability and the environmental impact.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15524&type=smp
Which Key Companies Are Shaping the Future of the Biopharmaceutical Fermentation Systems Market?
Major companies operating in the biopharmaceutical fermentation systems market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guérin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC
Which Factors Are Driving Demand in the Biopharmaceutical Fermentation Systems Industry?
The biopharmaceutical fermentation systems market is projected to grow as a result of the expanding biologics pipeline. Biologics are pharmaceutical products developed from living organisms or their components, such as vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The expansion of the biologics pipeline is due to advancements in biotechnology, better comprehension of disease mechanisms, and the need for targeted and personalized therapies. These fermentation systems are used in the production of biologics to grow genetically modified cells or microbes, enabling the large-scale production of complex therapeutic proteins, antibodies, and vaccines. For instance, the US-based National Library of Medicine revealed that in 2023, the Food and Drug Administration (FDA) gave approval to 55 new drugs, which included 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), showing a 50% increase when compared to the 37 approvals in 2022. Thus, the rise in the biologics pipeline is fueling the expansion of the biopharmaceutical fermentation systems market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=15524&type=smp
How Is the Biopharmaceutical Fermentation Systems Market Segmented by Several Divisions?
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
Subsegments:
1) By Upstream Products: Fermenters Or Bioreactors, Culture Media, Inoculum Preparation Systems, Gas And Liquid Flow Control Systems, Process Monitoring And Control Systems, Sterilization Systems
2) By Downstream Products: Filtration Systems, Centrifuges, Chromatography Systems, Ultrafiltration And Microfiltration Systems, Concentration And Purification Systems, Packaging And Storage Systems
What are the Emerging Market Trends Driving the Growth of the Biopharmaceutical Fermentation Systems Industry?
Leading enterprises in the biologics fermentation systems market are concentrating on crafting innovative fermentation systems like automated bioreactors to boost effectiveness, scalability, and repeatability. Automated bioreactors are state-of-the-art bio-processing systems that incorporate automated monitoring and control technologies to perfect growth conditions for cells or microorganisms in biopharmaceutical manufacturing. For example, Froilabo, a lab equipment firm based in France, debuted fully automated lab-scale bioreactors in October 2022. These bioreactors are purposely built to cater to different uses, including academia, research, process development, and production. Their design provides top-quality aseptic conditions with customizable options for the placement and variety of impellers, equipped with a new magnetic mixer, and a non-welded lid.
Access The Full Report Here:
Which Regions Are Driving Growth in the Biopharmaceutical Fermentation Systems Market?
North America was the largest region in the biopharmaceutical fermentation systems market in 2023. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15524
This Report Delivers Insight On:
1. How big is the biopharmaceutical fermentation systems market, and how is it changing globally?
2. Who are the major companies in the biopharmaceutical fermentation systems market, and how are they performing?
3. What are the key opportunities and risks in the biopharmaceutical fermentation systems market right now?
4. Which products or customer segments are growing the most in the biopharmaceutical fermentation systems market?
5. What factors are helping or slowing down the growth of the biopharmaceutical fermentation systems market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
